(ASND) Ascendis Pharma AS - Performance 28.3% in 12m
ASND performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
15.40%
#22 in Peer-Group
Rel. Strength
73.89%
#2005 in Stock-Universe
Total Return 12m
28.25%
#43 in Peer-Group
Total Return 5y
14.68%
#31 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 179.10 USD |
| 52 Week Low | 112.93 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 63.97 |
| Buy/Sell Signal +-5 | 1.14 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ASND (28.3%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ASND vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ASND
| Total Return (including Dividends) | ASND | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 0.28% | 3.36% | 5.25% |
| 3 Months | 22.09% | 15.73% | 24.13% |
| 12 Months | 28.25% | -7.02% | 14.15% |
| 5 Years | 14.68% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | ASND | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -3.4% | 4.4% | 81% |
| 3 Months | 78.1% | 78.8% | 96.9% |
| 12 Months | 67.1% | -85.8% | 44.9% |
| 5 Years | -8.4% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th52.50 | -2.97% | -4.72% |
| 3 Month | %th55.00 | 5.49% | -1.65% |
| 12 Month | %th79.00 | 37.94% | 12.35% |
| 5 Years | %th85.00 | 51.32% | -45.86% |
FAQs
Does Ascendis Pharma AS (ASND) outperform the market?
Yes,
over the last 12 months ASND made 28.25%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months ASND made 22.09%, while XBI made 15.73%.
Performance Comparison ASND vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ASND vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.6% | -5% | 18.5% | 14% |
| US NASDAQ 100 | QQQ | -0.3% | -5% | 17.9% | 16% |
| German DAX 40 | DAX | 1.6% | 1.7% | 6.4% | -1% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.4% | -3% | 15.1% | 8% |
| Hongkong Hang Seng | HSI | -0.2% | -5.8% | -0.9% | -10% |
| India NIFTY 50 | INDA | 1.3% | -3.2% | 18.2% | 29% |
| Brasil Bovespa | EWZ | -3% | -8.5% | -6.6% | 18% |
ASND vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.8% | -5.6% | 14.4% | 4% |
| Consumer Discretionary | XLY | -0.1% | -2.9% | 26.2% | 10% |
| Consumer Staples | XLP | -0.9% | -0.4% | 16.9% | 19% |
| Energy | XLE | -0.9% | -6.8% | 22.6% | 28% |
| Financial | XLF | -1.3% | -4.8% | 13.6% | -2% |
| Health Care | XLV | -0% | -1.9% | 25.9% | 33% |
| Industrial | XLI | -0.7% | -3.9% | 10.7% | 3% |
| Materials | XLB | -2.8% | -4% | 14% | 22% |
| Real Estate | XLRE | -0.5% | -0.7% | 18.8% | 15% |
| Technology | XLK | -1.3% | -8.4% | 16.2% | 17% |
| Utilities | XLU | 0.5% | -1.5% | 15.3% | 5% |
| Aerospace & Defense | XAR | 1.6% | -6.8% | -0.1% | -21% |
| Biotech | XBI | -1.6% | -3.1% | 31.7% | 35% |
| Homebuilder | XHB | -3.1% | -6.7% | 25.7% | 23% |
| Retail | XRT | -3.1% | -4.7% | 22.8% | 17% |
ASND vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1.5% | -8.16% | 26.9% | 36% |
| Natural Gas | UNG | 8.9% | 10.1% | 35.3% | 30% |
| Gold | GLD | -0.8% | 1.5% | -2.1% | -11% |
| Silver | SLV | -1.6% | -6.6% | 1.2% | 11% |
| Copper | CPER | 0.4% | -4.3% | 1.4% | 17% |
ASND vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.3% | -0.8% | 21.9% | 30% |
| iShares High Yield Corp. Bond | HYG | 0.6% | -1.3% | 19.6% | 18% |